Article ID Journal Published Year Pages File Type
5692404 Contraception 2017 7 Pages PDF
Abstract
Women with frequent ENG implant-related breakthrough bleeding may experience a reduction in bleeding/spotting days and an increase in continuous bleeding-free days in the month following first use of tamoxifen. This short course of tamoxifen was well tolerated with bleeding cessation noted within a median of 5 days.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Obstetrics, Gynecology and Women's Health
Preview
Tamoxifen for the treatment of breakthrough bleeding with the etonogestrel implant: a randomized controlled trial
Authors
, , , ,